Tags: moderna | fauci | shares | stock

Fauci Comments Boost Moderna Shares

Fauci Comments Boost Moderna Shares

Friday, 22 May 2020 08:49 AM

Moderna shares rose after Anthony Fauci, the leading U.S. infectious disease official, said he was optimistic about the company’s vaccine.

“Even though there were only eight individuals, we saw neutralizing antibodies at a reasonable dose of the vaccine,” Fauci said on CNN.

“Although the numbers were limited, it was really quite good news because it reached and went over an important hurdle in the development of vaccines. That’s the reason why I’m cautiously optimistic about it.”

Fauci said on NPR that he expects the full results of a Phase 1 study of the biotech’s experimental COVID-19 vaccine within weeks.

Earlier this week, an experimental vaccine from the company showed signs that it can create an immune-system response to fend off the new coronavirus.

In 25 people who got either of the two smaller doses used in the study, researchers reported that the levels of antibodies equaled or exceeded the levels of antibodies found in patients who had recovered from the virus.

The second test, evaluating the quality of those antibodies, was only available for eight of the people because it takes longer to perform. But in all eight people, the vaccine successfully stimulated the body to create antibodies capable of neutralizing the virus in the test tube, so it can no longer infect cells.

Moderna shares (MRNT) rose 4% in premarket trading to $69.85.

© Copyright 2020 Bloomberg News. All rights reserved.


   
1Like our page
2Share
StreetTalk
Moderna shares rose after Anthony Fauci, the leading U.S. infectious disease official, said he was optimistic about the company’s vaccine.
moderna, fauci, shares, stock
224
2020-49-22
Friday, 22 May 2020 08:49 AM
Newsmax Media, Inc.
 

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved